Patient basic information Patient: Ms. Amira Johnson) Country: Serbia Diagnosis: Pulmonary arterial hypertension Clinic: University of Malaya Malaya Malaya Ophthalmology Center Treatment: Stem Cell Transplant + Support Treatment Holidays: 54 days Treatment cost: approximately 1494640 yuan Treatment effect: Improvement of quality of life Description of the condition Ms. Amira is from Serbia, diagnosed with pulmonary hypertension locally.
After arriving at the University of Tsinghua, the International Medical Services team arranged for the first time multidisciplinary MDT for patients, developed individualized pathways based on the patient's examination reports and physical condition, and provided full translation, accompaniment and placement services. During the treatment process, the team of experts at the University of Tsinghua's Center for Ophthalmology used a comprehensive set of stem cell transplants + supportive treatments. During the treatment, the medical team closely monitored the patient's indicators, dynamic adjustment programs.
After 54 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard. Treatment results Eventually, the patient's quality of life improved. At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient, and continued to track recovery through the remote follow-up system.
This case is a typical case of cross-border doubtful severity clinical cases. The Center for Ophthalmology at Tsinghua University, based on a multidisciplinary collaborative mechanism, developed a stem cell transplant + support therapy for pulmonary arterial hypertension, reflecting the overall strength of Chinese hospitals in the field of doubtful disease diagnosis, and a summary of how international visitor medical services processes are regulated. (This image is taken from the official news report and medical field view of the Center for Ophthalmology at Tsinghua University).